Post–cardiac transplantation gout: incidence of therapeutic complications
- 1 October 2000
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 19 (10) , 951-956
- https://doi.org/10.1016/s1053-2498(00)00175-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- URATE OXIDASE IN HYPERURICEMIC HEART TRANSPLANT RECIPIENTS TREATED WITH AZATHIOPRINETransplantation, 1997
- Risks and Benefits of Drugs Used in the Management and Prevention of GoutDrug Safety, 1994
- Avascular necrosis of bone after cardiac transplantation. Prevalence and relationship to administration and dosage of steroids.Journal of Bone and Joint Surgery, 1994
- Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective studyNephrology Dialysis Transplantation, 1994
- Osteoporosis after cardiac transplantationThe American Journal of Medicine, 1993
- Hyperuricemia after kidney transplantation in patients treated with cyclosporineThe American Journal of Medicine, 1992
- Hyperuricemia and gout among heart transplant recipients receiving cyclosporineThe American Journal of Medicine, 1992
- Azathioprine and allopurinol: a potentially dangerous combinationJournal of Internal Medicine, 1990
- Gout in the heart transplant recipient: Physiologic puzzle and therapeutic challengeThe American Journal of Medicine, 1989
- NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND CYCLOSPORINE A POTENTIALLY SERIOUS ADVERSE INTERACTIONTransplantation, 1988